Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

In lab experiments, bacteria transferred plasmids with AMR genes in the presence of zinc at reduced or nonexistent rates. Stopping the transfer without killing microbes may help reduce AMR without ...

Unchained Labs, the life sciences company that's all about getting biologics and gene therapy researchers the right tool for ...

Earthworms could become unexpected allies in the global fight against antibiotic resistance, by helping farmers turn manure ...

Radiopharmaceuticals are one of the most exciting frontiers in oncology and targeted therapies today. By combining biologically active molecules with radionuclides, radiopharmaceuticals can deliver ...

Vaxcyte is positioned to disrupt the pneumococcal vaccine market with its engineered VAX-31, overcoming carrier suppression limitations faced by incumbents. PCVX's $2.7B cash position supports an ...

Focused on next-generation vaccines for bacterial diseases, this biotech just reported a notable insider sale amid a ...

Harpreet S. Dhaliwal, Chief Technical Ops Officer of Vaxcyte(NASDAQ:PCVX), disposed of 9,743 shares in an open-market sale valued at approximately $454,891 according to the SEC Form 4 filing.

An exhibition to be displayed tomorrow at the Knesset as part of a discussion on economic oppression against women has ...

Traditional multicolored Mexican fabrics were draped across tables and benches. Two men from a party-rentals company were ...

Google to help you stick to your New Year Resolutions!